Ca. Gray et al., Mechanisms regulating norgestomet inhibition of endometrial gland morphogenesis in the neonatal ovine uterus, MOL REPROD, 57(1), 2000, pp. 67-78
In many species, endometrial gland adenogenesis occurs neonatally in an ova
ry-and steroid-independent manner. Chronic exposure of the developing neona
tal ovine uterus to norgestomet (NOR) from birth permanently ablates endome
trial gland morphogenesis or adenogenesis, creating an adult ovine uterine
gland knockout (UGKO) phenotype. This study was conducted to determine the
mechanism(s) whereby NOR inhibits adenogenesis in the neonatal ewe. Ewe lam
bs received no implant or a NOR implant at birth and on postnatal day (PND)
14, and they were necropsied on PND28. Histological analyses of the tracts
indicated NOR exposure specifically inhibited endometrial adenogenesis, bu
t no histoarchitectural differences were observed in the oviduct, cervix, o
r vagina. No effect of NOR treatment was detected on proliferating cell nuc
lear antigen (PCNA) expression in the endometrial luminal epithelium (LE),
stroma, or myometrium. In control (CX) ewes, estrogen receptor alpha (ER-al
pha) and progesterone receptor (PR) mRNA and protein were expressed strongl
y in nascent and proliferating glandular epithelium (GE) but were undetecte
d in epithelium of NOR uteri. Expression of c-met and fibroblast growth fac
tor receptor 2IIIb (FGFR2IIIb) mRNA was detected in the LE and GE of CX ute
ri. In NOR uteri, c-met was expressed in the LE similar to CX uteri, but FG
FR2IIIb mRNA levels were lower than in the LE of CX uteri. Uterine hepatocy
te growth factor (HGF), the ligand for c-met, and FGFR2IIIb mRNA expression
was substantially lower in NOR ewes, but expression of FGF-7 and FGF-10 mR
NAs, ligands for FGFR2IIIb, was unaffected. These results indicate that NOR
disrupts endometrial adenogenesis by ablating epithelial ER-alpha expressi
on and altering expression of paracrine growth factors and/or receptors inv
olved in epjthelio-mesenchymal interactions. Likewise, these mechanisms are
proposed to be important regulators of normal uterine gland morphogenesis
in the neonate. (C) 2000 Wiley-Liss, Inc.